If a laser technology could address skin pigmentation with greater precision and efficacy, would you consider it? A new study is examining this possibility, though anonymous access to the research has been temporarily restricted until December 2025 due to suspected cybersecurity threats. Despite this, the core focus of the study remains clear: comparing the effectiveness of dual-wavelength picosecond lasers—532 nanometer (nm) and 1064 nm—in treating pigmentation disorders.
The Science Behind Picosecond Lasers
Picosecond lasers are renowned for their ultra-short pulse durations, which enable more precise targeting of pigment particles while minimizing damage to surrounding tissue. The dual-wavelength approach combines the advantages of two distinct wavelengths, theoretically allowing broader coverage across different pigment types and depths. The 532 nm wavelength is particularly effective for superficial epidermal pigments, while the 1064 nm wavelength penetrates deeper into the dermis to address subdermal pigmentation.
Clinical Implications
This prospective comparative study aims to evaluate the differences between these wavelengths in clinical applications, including efficacy, safety, and patient tolerance. The findings could provide dermatologists with evidence-based guidance to tailor treatments for individual needs. Although the full report is currently inaccessible, the research direction underscores promising advancements in treating pigmentation-related skin conditions.
Kontak Person: Mr. Frank
Tel: +8613826474063